Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inmune Bio (INMB) Non-cash Items (2018 - 2025)

Inmune Bio's Non-cash Items history spans 8 years, with the latest figure at $5.4 million for Q3 2025.

  • For Q3 2025, Non-cash Items rose 112.53% year-over-year to $5.4 million; the TTM value through Sep 2025 reached $5.4 million, up 112.53%, while the annual FY2024 figure was $1.2 million, 94.34% down from the prior year.
  • Non-cash Items for Q3 2025 was $5.4 million at Inmune Bio, roughly flat from $5.4 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $21.5 million in Q4 2023 and bottomed at $1.2 million in Q4 2024.
  • The 5-year median for Non-cash Items is $5.4 million (2025), against an average of $8.4 million.
  • The largest annual shift saw Non-cash Items soared 633.69% in 2021 before it tumbled 94.34% in 2024.
  • A 5-year view of Non-cash Items shows it stood at $11.2 million in 2021, then tumbled by 62.9% to $4.2 million in 2022, then surged by 417.67% to $21.5 million in 2023, then crashed by 94.34% to $1.2 million in 2024, then soared by 341.63% to $5.4 million in 2025.
  • Per Business Quant, the three most recent readings for INMB's Non-cash Items are $5.4 million (Q3 2025), $5.4 million (Q2 2025), and $9.4 million (Q1 2025).